May 2005
Volume 46, Issue 13
ARVO Annual Meeting Abstract  |   May 2005
PDT of Corneal Neovessels Using a New Hydrosoluble Photosensitizer (WST11)
Author Affiliations & Notes
  • D. BenEzra
    Department of Ophthalmology, Hadassah University Hospital, Jerusalem, Israel
    INSERM U–598, Paris, France
  • R.A. Bejjani
    Ophthalmology, INSERM U–598, Hôtel–Dieu Hospital, Paris, France
  • M. Savoldelli
    INSERM U–598, Paris, France
  • F. Valamanesh
    INSERM U–598, Paris, France
  • J.C. Jeanny
    INSERM U–598, Paris, France
  • D. Blanc
    Negma Lerads, Toussus le Noble, France
  • D. Prowedini
    Negma Lerads, Toussus le Noble, France
  • F.F. Behar–Cohen
    INSERM U–598, Paris, France
    Ophthalmology, Rothschild Ophthalmic Foundation, Paris, France
  • Footnotes
    Commercial Relationships  D. BenEzra, None; R.A. Bejjani, None; M. Savoldelli, None; F. Valamanesh, None; J.C. Jeanny, None; D. Blanc, Negma Lerads, Toussus le Noble , France E; D. Prowedini, Negma Lerads, Toussus le Noble , France E; F.F. Behar–Cohen, None.
  • Footnotes
    Support  NEGMA–LERADS, Toussus Le Noble, France
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 4498. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      D. BenEzra, R.A. Bejjani, M. Savoldelli, F. Valamanesh, J.C. Jeanny, D. Blanc, D. Prowedini, F.F. Behar–Cohen; PDT of Corneal Neovessels Using a New Hydrosoluble Photosensitizer (WST11) . Invest. Ophthalmol. Vis. Sci. 2005;46(13):4498.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Abstract: : Purpose:To evaluate the photodynamic treatment (PDT) potential and safety of a new hydrosoluble photosensitizer (WST11) on rabbit corneal neovessels (NV). Methods: Elvax 40 implants sequestering 75µg of LPS are implanted in the rabbit cornea at 3mm from the limbus. For PDT, WST11 in 5% glucose is infused IV during 3 minutes and a 3.5 mm laser beam (753nm, 600mW/cm2) is used. To screen for best occlusive parameters, 2 doses of WST11 (5 and 10mg/Kg), 2 laser fluences (70 and 140J/cm2) with 1’ or 5’ distance to light illumination (DLI) were evaluated (n=6/condition). The treated NV are examined clinically during the period of laser delivery. At 2 hours, 2 and 8 days after PDT, the eyes are enucleated, fixed and semi–thin sections prepared. Results:During PDT a bleaching of the laser illuminated zone surrounded by a ring of relative vasodilation is observed clinically. Immediately after the laser delivery, partial vascular occlusion of the treated area is clinically observed in 33% of the eyes receiving 70 J/cm2, WST11 5mg/Kg, DLI1min and only in 15% when the DLI is 5min. Eyes treated with 70 J/cm2, WST11 10mg/Kg, DLI1min show partial vascular occlusion in 100%of the cases and only in 66%of the cases when the DLI is 5min. Total occlusion of the irradiated vascular bed occurred in 100% of the eyes treated with 140J/cm2, WST11 10mg/Kg, DLI 1min and in 75% of the eyes with a DLI of 5 min. No signs of corneal or other ocular structure toxicity, inflammation or intraocular hemorrhages occurred following the delivery of the above PDT protocols. Histology analysis of the treated corneal areas demonstrate that two hours after PDT, vascular stasis associated with intracellular alterations of the endothelial cells but no vessel wall rupture takes place. On day 2 and 8 after treatment, NV occlusion persisted in the eyes treated with the highest parameters. However, on day 8 post treatment patent NV are observed within the previously treated (and occluded) vascular zone. No collateral lesions or damage of the adjacent corneal tissues is observed and the endothelial cell layer remains intact throughout. Conclusions:PDT effect of the new photosensitizer WST11 is closely associated with the DLI used and probably due to its rapid elimination from the circulation. Selective PDT parameters with WST11 result in an efficient, safe and continuous occlusion of corneal NV.

Keywords: neovascularization • photodynamic therapy • vascular cells 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.